Welcome to INSPECT- Indiana's Prescription Monitoring Program!
ALL REPORTING PHARMACIES:
ATTENTION- Effective July 1, 2016, pursuant to Ind. Code 25-26-13-4, ephedrine and pseudoephedrine, when dispensed via prescription, are each considered a"controlled substance" for the purposes of the INSPECT program. All prescription dispensations of these drugs must be reported to INSPECT. Over-the-counter purchases are not reported to INSPECT and must still be processed through NPLEx.
ATTENTION- Effective July 1, 2016, pursuant to Ind. Code 35-48-2-8(c)(3), Butalbital,commonly known as Fioricet, is a Schedule III substance in the State of Indiana. As a result,Schedule III requirements in the Indiana Controlled Substances Act and associated administrative rules in 856 IAC 2 apply to its handling and dispensation.
The Indiana Board of Pharmacy will enforce Schedule III requirements for Butalbital 60 days from the date of this communication. Please note specifically that existing prescriptions will be valid but refills outside of that allowed under Schedule III will be invalid. Further, as a Schedule III substance, an initial inventory is needed and Butalbital must be included in your biennial inventory.
Beginning April 15, 2016: INSPECT will no longer accept reports using ASAP 4.0
If after this date you continue to report using ASAP 4.0 your report will not be accepted and you will be deemed non-compliant in reporting to INSPECT.
The Inspect Helpdesk is supported and maintained by Appriss, Inc. which will promptly provide assistance.
Phone: (844) 446-4767
Please be sure to provide your Contact Information (Name, Organization, Phone, and Email) along with your description of the incident.